Published in Respir Res on December 04, 2006
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.92
Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children. Cochrane Database Syst Rev (2009) 0.85
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl (1993) 20.55
Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (2000) 9.44
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis (1987) 6.69
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med (2004) 4.37
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study. Lancet (2006) 3.93
Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial. Lancet (2001) 2.68
A comparison of the visual analogue scale and modified Borg scale for the measurement of dyspnoea during exercise. Clin Sci (Lond) (1989) 2.06
Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J (2003) 1.84
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J (2005) 1.70
Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin (2004) 1.57
Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. Respir Med (2004) 1.48
Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma. Chest (2003) 1.42
Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs (2000) 1.26
Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther (2004) 1.19
Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone. Eur Respir J (2001) 1.16
Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther (2005) 1.12
Oxis (formoterol given by Turbuhaler) showed as rapid an onset of action as salbutamol given by a pMDI. Respir Med (2000) 1.12
Formoterol (OXIS) Turbuhaler as a rescue therapy compared with salbutamol pMDI plus spacer in patients with acute severe asthma. Respir Med (2003) 1.02
Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction. Eur Respir J (1999) 0.99
Teaching old drugs new tricks: asthma therapy adjusted by patient perception or noninvasive markers. Eur Respir J (2005) 0.90
Budesonide/formoterol and formoterol provide similar rapid relief in patients with acute asthma showing refractoriness to salbutamol. Respir Res (2006) 0.89
A single inhaler for asthma? Am J Respir Crit Care Med (2005) 0.88
Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Respir Med (2003) 0.86
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med (2003) 0.85
Formoterol Turbuhaler as reliever medication in patients with acute asthma. Eur Respir J (2006) 0.84
Improved lung function and symptom control with formoterol on demand in asthma. Eur Respir J (2006) 0.82
Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients. Pulm Pharmacol Ther (2002) 0.81
A comparison of the onset of action of salbutamol and formoterol in reversing methacholine-induced bronchoconstriction. Respir Med (1998) 0.80
Relief of dyspnoea by beta2-agonists after methacholine-induced bronchoconstriction. Respir Med (2004) 1.48
Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol (2011) 1.46
Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers. Chest (2005) 1.33
Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther (2004) 1.19
The relationship between self-efficacy and self-reported physical functioning in chronic obstructive pulmonary disease and chronic heart failure. Behav Med (2005) 0.95
Combination therapy with single inhaler budesonide/formoterol compared with high dose of fluticasone propionate alone in patients with moderate persistent asthma. Am J Respir Med (2003) 0.85
Extent of uncontrolled disease and associated medical costs in severe asthma--a PHARMO study. Curr Med Res Opin (2008) 0.84
[Treatment of asthma during pregnancy]. Ned Tijdschr Geneeskd (2009) 0.81
Long-acting beta2-agonists: comparative pharmacology and clinical outcomes. Am J Respir Med (2002) 0.77
Comparison and optimal use of fixed combinations in the management of COPD. Int J Chron Obstruct Pulmon Dis (2007) 0.76
Onset of action of formoterol versus salmeterol. Respir Med (2007) 0.75
Effects of short-acting bronchodilators added to maintenance tiotropium therapy. Chest (2007) 0.75